Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVATE II trial of BCG vaccination for prevention of COVID-19
2020-002448-21Phase 4Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- May 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing BCG vaccine with Placebo (2 arms). Primary endpoint: Primary composite endpoint. Started May 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002448-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002448-21.